TB-500
Also known as: Thymosin Beta-4 fragment, TB4 fragment
Synthetic fragment of Thymosin Beta-4 active site. Studied for actin sequestration, cell migration, and tissue repair.
Who's worth your money for TB-500
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (99) of 33 scored sellers
$58.99 · 10mg · 99.9% purity
Best value after code
$0.06/mg effective with 15% code
$0.65 · 10mg · 99.3% purity
Most tested
57 independent COAs on file
$37.20 · 10mg · 99.0% purity
Average price
$7.47/mg
Sellers
87
45-day trend
-7.5%
74 of 87 sellers have a current price· 29 stale hidden· 12 unverified hidden
Top Merit pick
🇺🇸 Glacier Aminos99✓ verified at source · just now
$5.90/mg -21% vs avg$58.99
10mg
- 🇺🇸 Hydro Research Peptides97
✓ verified at source · just now
$0.07/mg -99.1% vs avg$0.65
10mg
- 🇺🇸 Moglabs96
✓ verified at source · just now
$7.60/mg +1.8% vs avg$38.00
5mg
- 🇺🇸 BioLongevity Labs96
✓ verified at source · just now
$16.50/mg +120.9% vs avg$165
10mg
- 🇺🇸 Prime Peptides95
✓ verified at source · just now
$6.50/mg -13% vs avg$65.00
10mg
- 🇺🇸 Licensed Peptides95
✓ verified at source · just now
$10.00/mg +33.9% vs avg$99.99
10mg
- Nova Peptides94
✓ verified at source · just now
$3.50/mg -53.1% vs avg$34.99
10mg
- 🇺🇸 Forge Performance Co.94
✓ verified at source · just now
$6.00/mg -19.7% vs avg$60.00
10mg
- 🇺🇸 Peptide Crafters94
✓ verified at source · just now
$6.38/mg -14.6% vs avg$63.75
10mg
no purityBuy code CRAFTERS10 · 10% off - 🇺🇸 Ignite Peptides93
✓ verified at source · just now
$6.50/mg -13% vs avg$65.00
10mg
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch TB-500
Get one email when the market actually moves — no newsletter, no noise.
About TB-500
CAS
885340-08-9
Molecular formula
C38H68N10O14
Sequence
LKKTETQ
Typical dose range
2–5 mg subcutaneous or intramuscular, 1–2x per week; loading phase typically 4–6 weeks
Half-life
~1–2 hours (plasma; based on equine and in vitro studies)
Common research uses
Safety notes
WADA-prohibited (S2 class). Not FDA-approved for human therapeutic use.
Reconstitution
Reconstitute with bacteriostatic water; stable refrigerated for ~4 weeks.
COAs for TB-500
229 third-party tests across 42 vendors. Each card links to the full report.
For
TB-500(TB-4)
by Ignite Peptides· batch IP-2607-898
For
TB-500
by NG Peptide· batch TB10-08
For
TB-500
by EZ Peptides· batch EZP-TBF1006172026-06
For
TB-500
by Ion Peptide· batch TB10-06092026
For
TB-500
by Ion Peptide· batch TB10-06092026
For
TB-500 (TB-4)
by optimasupply.is· batch OS-2026-9422
For
TB-500
by EZ Peptides· batch EZP-TBF1005142026-05
For
TB-500
by True Peptide· batch TB50--060-TPL
For
TB-500 (TB4)
by Peptide Partners· batch SPL-3956
For
TB-500
by Prime Peptides· batch 4142026TB
For
TB-500 (Tβ4)
by Moglabs· batch TB002
For
TB-500 (Tβ4)
by Arcane Peptides· batch TB002
For
TB-500 (TB4)
by Arcane Peptides· batch TB002
For
TB-500 (TB4)
by Moglabs· batch TB002
For
TB-500
by Ion Peptide· batch TB20-05072026
For
TB-500
by Prime Peptides· batch 4062026TB
For
TB-500
by Verified Peptides· batch TB042609101
For
TB-500
by Verified Peptides· batch FTB06260510E
For
TB-500
by Verified Peptides· batch FTB06260510E
For
Frag(17-23) TB-500
by Verified Peptides· batch FTB0626Q510E
For
TB-500
by Modern Research Peptides· batch BCEN27169
For
TB-500
by NG Peptide· batch TB20-5
For
TB-500
by NG Peptide· batch TB20-5
For
TB-500
by Ion Peptide· batch TB10-05042026
15 citations indexed for TB-500
animal · 2026
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study
Objectives This study aims to evaluate the effects of BPC-157, synthetic thymosin beta-4 (TB-500), and their combination on Achilles tendon healing using biomechanical, histopathological, histochemical, and immunohistochemical analyses in a rat model.
Study · 2026
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
Background The peptide supplement market has experienced rapid growth due to marketing claims of enhanced performance and accelerated recovery from musculoskeletal injury.
review · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
review · 2026
Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management
Purpose of review This narrative review summarizes the current evidence on regenerative peptides relevant to chronic pain management, including collagen peptides, body protection compound-157 (BPC-157), thymosin beta-4 (TB-4), thymosin beta-500 (TB-500), glycyl-L-histidyl-L-lysine copper (GHK-Cu), growth hormone-relate…
review · 2026
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Background Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients.
review · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.